Eileen R. Roux
- Immunology top 0.5%
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 5%
- Hematology top 2%
- Co-authors
- Eugene MaraskovskyMark TeepeStewart D. LymanKenneth BraselDirk AndersonMark TometskoRobert DuBoseWilliam C. Dougall
- Topics
- Immunotherapy and Immune Responses (7 papers)T-cell and B-cell Immunology (7 papers)Immune Cell Function and Interaction (7 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
Eileen R. Roux
15 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology 2.8k
- Molecular Biology 2.2k
- Oncology 1.6k
- Cancer Research 625
- Hematology 368
Countries citing papers authored by Eileen R. Roux
This map shows the geographic impact of Eileen R. Roux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen R. Roux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen R. Roux more than expected).
Fields of papers citing papers by Eileen R. Roux
This network shows the impact of papers produced by Eileen R. Roux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen R. Roux. The network helps show where Eileen R. Roux may publish in the future.
Co-authorship network of co-authors of Eileen R. Roux
This figure shows the co-authorship network connecting the top 25 collaborators of Eileen R. Roux. A scholar is included among the top collaborators of Eileen R. Roux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen R. Roux. Eileen R. Roux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 39 | |
| 2 | Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cellsbreakdown → | 686 |
| 3 | 322 | |
| 4 | 69 | |
| 5 | 48 | |
| 6 | 57 | |
| 7 | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionbreakdown → | 1824 |
| 8 | 1 | |
| 9 | 5 | |
| 10 | Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.breakdown → | 934 |
| 11 | 3 | |
| 12 | 203 | |
| 13 | 96 | |
| 14 | Fas transduces activation signals in normal human T lymphocytes.breakdown → | 460 |
| 15 | Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF). | 10 |
About Eileen R. Roux
Eileen R. Roux is a scholar working on Immunology, Hematology and Pharmacy, having authored 15 papers that have together received 4.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Immunology (2.8k citations), Oncology (1.6k citations) and Cancer Research (625 citations). Eileen R. Roux has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Eugene Maraskovsky, Mark Teepe, Stewart D. Lyman, Kenneth Brasel, Dirk Anderson, Mark Tometsko, Robert DuBose, William C. Dougall, Laurent Galibert and David Cosman. Their work appears in journals such as Nature, The Journal of Experimental Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.